During the past decade, MD Stem Cells conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "MD Stem Cells" are "Alzheimer Disease" (2 trials), "Cadasil" (2 trials), "Chronic Traumatic Encephalopathy" (2 trials), "Glaucoma" (2 trials) and "Lewy Body Disease" (2 trials). Many other conditions were trialed in "MD Stem Cells" in a lesser frequency.

Most popular intervention types in "MD Stem Cells" are "Procedure" (4 trials). Other intervention types were less common.

The name of intervention was led by "Arm 1" (1 trials), "IO (Intraocular)" (1 trials), "IV (Intravenous)" (1 trials), "IVIT (Intravitreal)" (1 trials) and "Intranasal Topical Bone Marrow Stem Cell (BMSC) Fraction" (1 trials). Other intervention names were less common.

The vast majority of trials in "MD Stem Cells" are 4 trials for "All" genders.

Currently, there are NaN active trials in "MD Stem Cells". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were undefined completed trials in MD Stem Cells, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in MD Stem Cells, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 4 trials that are defined as “Not Applicable".